TCL Archive Centers Eligible For Comprehensive Identification Names; Rauscher To Pick Four Now, Two More Later May 24, 1974
TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study February 23, 2007
TCL Archive In Brief: NCI Will Stop Free Group C distribution Of VP-16 Sept. 1 Unless Bristol Supplies It At No Charge June 25, 1982
